ID   PO210_HUMAN             Reviewed;        1887 AA.
AC   Q8TEM1; A6NN56; O94980; Q6NXG6; Q8NBJ1; Q9H6C8; Q9UFP3;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   28-JUN-2023, entry version 167.
DE   RecName: Full=Nuclear pore membrane glycoprotein 210;
DE            Short=Nuclear pore protein gp210;
DE   AltName: Full=Nuclear envelope pore membrane protein POM 210;
DE            Short=POM210;
DE   AltName: Full=Nucleoporin Nup210;
DE   AltName: Full=Pore membrane protein of 210 kDa;
DE   Flags: Precursor;
GN   Name=NUP210; Synonyms=KIAA0906; ORFNames=PSEC0245;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 763-1887 (ISOFORM 1), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 412-1887 (ISOFORM 2), AND VARIANT LEU-786.
RC   TISSUE=Brain, and Spleen;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 965-1887 (ISOFORM 1), VARIANTS
RP   SER-1752 AND MET-1787, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1405-1887 (ISOFORM 1), AND
RP   VARIANTS SER-1752 AND MET-1787.
RC   TISSUE=Ovary tumor;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1460-1887 (ISOFORM 1), AND
RP   VARIANTS SER-1752 AND MET-1787.
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=2195063; DOI=10.1172/jci114696;
RA   Courvalin J.-C., Lassoued K., Bartnik E., Blobel G., Wozniak R.W.;
RT   "The 210-kD nuclear envelope polypeptide recognized by human autoantibodies
RT   in primary biliary cirrhosis is the major glycoprotein of the nuclear
RT   pore.";
RL   J. Clin. Invest. 86:279-285(1990).
RN   [8]
RP   FUNCTION.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=14517331; DOI=10.1091/mbc.e03-04-0260;
RA   Cohen M., Feinstein N., Wilson K.L., Gruenbaum Y.;
RT   "Nuclear pore protein gp210 is essential for viability in HeLa cells and
RT   Caenorhabditis elegans.";
RL   Mol. Biol. Cell 14:4230-4237(2003).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1874; SER-1881 AND SER-1886,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-405; ASN-926 AND ASN-1441.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1844; SER-1874 AND SER-1881,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1844; SER-1874 AND SER-1881,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1844, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1844; SER-1874; SER-1877 AND
RP   SER-1881, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1844, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [18]
RP   VARIANT LEU-786, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=17488105; DOI=10.1021/pr0700908;
RA   Bunger M.K., Cargile B.J., Sevinsky J.R., Deyanova E., Yates N.A.,
RA   Hendrickson R.C., Stephenson J.L. Jr.;
RT   "Detection and validation of non-synonymous coding SNPs from orthogonal
RT   analysis of shotgun proteomics data.";
RL   J. Proteome Res. 6:2331-2340(2007).
CC   -!- FUNCTION: Nucleoporin essential for nuclear pore assembly and fusion,
CC       nuclear pore spacing, as well as structural integrity.
CC       {ECO:0000269|PubMed:14517331}.
CC   -!- SUBUNIT: Forms dimers and possibly higher-order oligomers.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q8TEM1; Q9NRI5: DISC1; NbExp=2; IntAct=EBI-372826, EBI-529989;
CC   -!- SUBCELLULAR LOCATION: Nucleus, nuclear pore complex
CC       {ECO:0000269|PubMed:2195063}. Nucleus membrane
CC       {ECO:0000269|PubMed:2195063}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:2195063}. Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:2195063}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:2195063}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TEM1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TEM1-2; Sequence=VSP_018567, VSP_018568;
CC   -!- TISSUE SPECIFICITY: Ubiquitous expression, with highest levels in lung,
CC       liver, pancreas, testis, and ovary, intermediate levels in brain,
CC       kidney, and spleen, and lowest levels in heart and skeletal muscle.
CC       {ECO:0000269|PubMed:10048485}.
CC   -!- PTM: N-glycosylated, but not all potential glycosylation sites may be
CC       used. Contains high-mannose type oligosaccharides (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated at Ser-1881 in mitosis specifically; not
CC       phosphorylated in interphase. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Recognized by antinuclear autoantibodies in primary
CC       biliary cirrhosis.
CC   -!- MISCELLANEOUS: Knockdown of NUP210 causes nuclear membranes to
CC       accumulate aberrant structures termed twinned and fusion-arrested
CC       membranes and nuclear pore complex to cluster. Induces cell death and
CC       chromatin disruptions.
CC   -!- SIMILARITY: Belongs to the NUP210 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15332.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAC11688.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC027124; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC069246; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC067089; AAH67089.1; -; mRNA.
DR   EMBL; AK026042; BAB15332.1; ALT_INIT; mRNA.
DR   EMBL; AK074101; BAB84927.1; -; mRNA.
DR   EMBL; AB020713; BAA74929.1; -; mRNA.
DR   EMBL; AK075545; BAC11688.1; ALT_INIT; mRNA.
DR   EMBL; AL117527; CAB55979.2; -; mRNA.
DR   CCDS; CCDS33704.1; -. [Q8TEM1-1]
DR   PIR; T17289; T17289.
DR   RefSeq; NP_079199.2; NM_024923.3. [Q8TEM1-1]
DR   PDB; 7R5J; EM; 50.00 A; 10/11/12/13/14/15/16/17=1-1887.
DR   PDB; 7R5K; EM; 12.00 A; 10/11/12/13/14/15/16/17=1-1887.
DR   PDBsum; 7R5J; -.
DR   PDBsum; 7R5K; -.
DR   AlphaFoldDB; Q8TEM1; -.
DR   SMR; Q8TEM1; -.
DR   BioGRID; 116831; 176.
DR   ComplexPortal; CPX-873; Nuclear pore complex.
DR   IntAct; Q8TEM1; 66.
DR   MINT; Q8TEM1; -.
DR   STRING; 9606.ENSP00000254508; -.
DR   TCDB; 1.I.1.1.3; the nuclear pore complex (npc) family.
DR   GlyConnect; 1579; 8 N-Linked glycans (5 sites).
DR   GlyCosmos; Q8TEM1; 12 sites, 7 glycans.
DR   GlyGen; Q8TEM1; 14 sites, 9 N-linked glycans (5 sites), 1 O-linked glycan (1 site).
DR   iPTMnet; Q8TEM1; -.
DR   PhosphoSitePlus; Q8TEM1; -.
DR   SwissPalm; Q8TEM1; -.
DR   BioMuta; NUP210; -.
DR   DMDM; 116242720; -.
DR   EPD; Q8TEM1; -.
DR   jPOST; Q8TEM1; -.
DR   MassIVE; Q8TEM1; -.
DR   MaxQB; Q8TEM1; -.
DR   PaxDb; Q8TEM1; -.
DR   PeptideAtlas; Q8TEM1; -.
DR   ProteomicsDB; 74472; -. [Q8TEM1-1]
DR   ProteomicsDB; 74473; -. [Q8TEM1-2]
DR   Antibodypedia; 10858; 223 antibodies from 27 providers.
DR   DNASU; 23225; -.
DR   Ensembl; ENST00000254508.7; ENSP00000254508.5; ENSG00000132182.13. [Q8TEM1-1]
DR   GeneID; 23225; -.
DR   KEGG; hsa:23225; -.
DR   MANE-Select; ENST00000254508.7; ENSP00000254508.5; NM_024923.4; NP_079199.2.
DR   UCSC; uc003bxv.3; human. [Q8TEM1-1]
DR   AGR; HGNC:30052; -.
DR   CTD; 23225; -.
DR   DisGeNET; 23225; -.
DR   GeneCards; NUP210; -.
DR   HGNC; HGNC:30052; NUP210.
DR   HPA; ENSG00000132182; Tissue enhanced (bone marrow, lymphoid tissue).
DR   MIM; 607703; gene.
DR   neXtProt; NX_Q8TEM1; -.
DR   OpenTargets; ENSG00000132182; -.
DR   PharmGKB; PA128394614; -.
DR   VEuPathDB; HostDB:ENSG00000132182; -.
DR   eggNOG; KOG1833; Eukaryota.
DR   GeneTree; ENSGT00390000009491; -.
DR   HOGENOM; CLU_001205_1_1_1; -.
DR   InParanoid; Q8TEM1; -.
DR   OMA; LNAFIRW; -.
DR   OrthoDB; 6312at2759; -.
DR   PhylomeDB; Q8TEM1; -.
DR   TreeFam; TF313331; -.
DR   PathwayCommons; Q8TEM1; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-165054; Rev-mediated nuclear export of HIV RNA.
DR   Reactome; R-HSA-168271; Transport of Ribonucleoproteins into the Host Nucleus.
DR   Reactome; R-HSA-168276; NS1 Mediated Effects on Host Pathways.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-168333; NEP/NS2 Interacts with the Cellular Export Machinery.
DR   Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-HSA-180746; Nuclear import of Rev protein.
DR   Reactome; R-HSA-180910; Vpr-mediated nuclear import of PICs.
DR   Reactome; R-HSA-191859; snRNP Assembly.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3232142; SUMOylation of ubiquitinylation proteins.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-4085377; SUMOylation of SUMOylation proteins.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5619107; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC).
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   Reactome; R-HSA-9609690; HCMV Early Events.
DR   Reactome; R-HSA-9610379; HCMV Late Events.
DR   Reactome; R-HSA-9705671; SARS-CoV-2 activates/modulates innate and adaptive immune responses.
DR   SignaLink; Q8TEM1; -.
DR   SIGNOR; Q8TEM1; -.
DR   BioGRID-ORCS; 23225; 21 hits in 1168 CRISPR screens.
DR   ChiTaRS; NUP210; human.
DR   GenomeRNAi; 23225; -.
DR   Pharos; Q8TEM1; Tbio.
DR   PRO; PR:Q8TEM1; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q8TEM1; protein.
DR   Bgee; ENSG00000132182; Expressed in endometrium epithelium and 160 other tissues.
DR   Genevisible; Q8TEM1; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IDA:ComplexPortal.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005643; C:nuclear pore; IBA:GO_Central.
DR   GO; GO:0051028; P:mRNA transport; IEA:UniProtKB-KW.
DR   GO; GO:0006913; P:nucleocytoplasmic transport; NAS:ComplexPortal.
DR   GO; GO:0015031; P:protein transport; IEA:UniProtKB-KW.
DR   InterPro; IPR003343; Big_2.
DR   InterPro; IPR008964; Invasin/intimin_cell_adhesion.
DR   InterPro; IPR045197; NUP210-like.
DR   PANTHER; PTHR23019:SF2; NUCLEAR PORE MEMBRANE GLYCOPROTEIN 210; 1.
DR   PANTHER; PTHR23019; NUCLEAR PORE MEMBRANE GLYCOPROTEIN GP210-RELATED; 1.
DR   Pfam; PF02368; Big_2; 1.
DR   SMART; SM00635; BID_2; 1.
DR   SUPFAM; SSF49373; Invasin/intimin cell-adhesion fragments; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Endoplasmic reticulum; Glycoprotein;
KW   Membrane; mRNA transport; Nuclear pore complex; Nucleus; Phosphoprotein;
KW   Protein transport; Reference proteome; Signal; Translocation;
KW   Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000250"
FT   CHAIN           27..1887
FT                   /note="Nuclear pore membrane glycoprotein 210"
FT                   /id="PRO_0000236046"
FT   TOPO_DOM        27..1808
FT                   /note="Perinuclear space"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        1809..1829
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1830..1887
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          1078..1151
FT                   /note="BIG2"
FT                   /evidence="ECO:0000255"
FT   REGION          1853..1887
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1844
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         1874
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1877
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1881
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1886
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   CARBOHYD        44
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        337
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        405
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        484
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        681
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        801
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        926
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        1039
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1116
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1135
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1362
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1441
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   VAR_SEQ         947..967
FT                   /note="HPLLPGSSTIMIHDLCLVFPA -> SLGHRSPLLVFIPYLGCCVVN (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018567"
FT   VAR_SEQ         968..1887
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018568"
FT   VARIANT         297
FT                   /note="A -> T (in dbSNP:rs7628051)"
FT                   /id="VAR_028147"
FT   VARIANT         608
FT                   /note="I -> V (in dbSNP:rs3732671)"
FT                   /id="VAR_028148"
FT   VARIANT         755
FT                   /note="A -> V (in dbSNP:rs6795271)"
FT                   /id="VAR_028149"
FT   VARIANT         786
FT                   /note="R -> L (confirmed at protein level;
FT                   dbSNP:rs2280084)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17488105"
FT                   /id="VAR_026474"
FT   VARIANT         821
FT                   /note="P -> A (in dbSNP:rs2280085)"
FT                   /id="VAR_028150"
FT   VARIANT         944
FT                   /note="A -> P (in dbSNP:rs433032)"
FT                   /id="VAR_028151"
FT   VARIANT         1096
FT                   /note="M -> I (in dbSNP:rs2271505)"
FT                   /id="VAR_028152"
FT   VARIANT         1430
FT                   /note="D -> E (in dbSNP:rs13081937)"
FT                   /id="VAR_028153"
FT   VARIANT         1752
FT                   /note="L -> S (in dbSNP:rs354479)"
FT                   /evidence="ECO:0000269|PubMed:10048485,
FT                   ECO:0000269|PubMed:16303743, ECO:0000269|PubMed:17974005"
FT                   /id="VAR_026475"
FT   VARIANT         1787
FT                   /note="V -> M (in dbSNP:rs354478)"
FT                   /evidence="ECO:0000269|PubMed:10048485,
FT                   ECO:0000269|PubMed:16303743, ECO:0000269|PubMed:17974005"
FT                   /id="VAR_026476"
FT   CONFLICT        1512
FT                   /note="A -> T (in Ref. 5; BAC11688)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1761
FT                   /note="P -> S (in Ref. 5; BAC11688)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1887 AA;  205111 MW;  70B5C35E685C8DF8 CRC64;
     MAARGRGLLL LTLSVLLAAG PSAAAAKLNI PKVLLPFTRA TRVNFTLEAS EGCYRWLSTR
     PEVASIEPLG LDEQQCSQKA VVQARLTQPA RLTSIIFAED ITTGQVLRCD AIVDLIHDIQ
     IVSTTRELYL EDSPLELKIQ ALDSEGNTFS TLAGLVFEWT IVKDSEADRF SDSHNALRIL
     TFLESTYIPP SYISEMEKAA KQGDTILVSG MKTGSSKLKA RIQEAVYKNV RPAEVRLLIL
     ENILLNPAYD VYLMVGTSIH YKVQKIRQGK ITELSMPSDQ YELQLQNSIP GPEGDPARPV
     AVLAQDTSMV TALQLGQSSL VLGHRSIRMQ GASRLPNSTI YVVEPGYLGF TVHPGDRWVL
     ETGRLYEITI EVFDKFSNKV YVSDNIRIET VLPAEFFEVL SSSQNGSYHR IRALKRGQTA
     IDAALTSVVD QDGGVHILQV PVWNQQEVEI HIPITLYPSI LTFPWQPKTG AYQYTIRAHG
     GSGNFSWSSS SHLVATVTVK GVMTTGSDIG FSVIQAHDVQ NPLHFGEMKV YVIEPHSMEF
     APCQVEARVG QALELPLRIS GLMPGGASEV VTLSDCSHFD LAVEVENQGV FQPLPGRLPP
     GSEHCSGIRV KAEAQGSTTL LVSYRHGHVH LSAKITIAAY LPLKAVDPSS VALVTLGSSK
     EMLFEGGPRP WILEPSKFFQ NVTAEDTDSI GLALFAPHSS RNYQQHWILV TCQALGEQVI
     ALSVGNKPSL TNPFPAVEPA VVKFVCAPPS RLTLAPVYTS PQLDMSCPLL QQNKQVVPVS
     SHRNPRLDLA AYDQEGRRFD NFSSLSIQWE STRPVLASIE PELPMQLVSQ DDESGQKKLH
     GLQAILVHEA SGTTAITATA TGYQESHLSS ARTKQPHDPL VPLSASIELI LVEDVRVSPE
     EVTIYNHPGI QAELRIREGS GYFFLNTSTA DVVKVAYQEA RGVAMVHPLL PGSSTIMIHD
     LCLVFPAPAK AVVYVSDIQE LYIRVVDKVE IGKTVKAYVR VLDLHKKPFL AKYFPFMDLK
     LRAASPIITL VALDEALDNY TITFLIRGVA IGQTSLTASV TNKAGQRINS APQQIEVFPP
     FRLMPRKVTL LIGATMQVTS EGGPQPQSNI LFSISNESVA LVSAAGLVQG LAIGNGTVSG
     LVQAVDAETG KVVIISQDLV QVEVLLLRAV RIRAPIMRMR TGTQMPIYVT GITNHQNPFS
     FGNAVPGLTF HWSVTKRDVL DLRGRHHEAS IRLPSQYNFA MNVLGRVKGR TGLRVVVKAV
     DPTSGQLYGL ARELSDEIQV QVFEKLQLLN PEIEAEQILM SPNSYIKLQT NRDGAASLSY
     RVLDGPEKVP VVHVDEKGFL ASGSMIGTST IEVIAQEPFG ANQTIIVAVK VSPVSYLRVS
     MSPVLHTQNK EALVAVPLGM TVTFTVHFHD NSGDVFHAHS SVLNFATNRD DFVQIGKGPT
     NNTCVVRTVS VGLTLLRVWD AEHPGLSDFM PLPVLQAISP ELSGAMVVGD VLCLATVLTS
     LEGLSGTWSS SANSILHIDP KTGVAVARAV GSVTVYYEVA GHLRTYKEVV VSVPQRIMAR
     HLHPIQTSFQ EATASKVIVA VGDRSSNLRG ECTPTQREVI QALHPETLIS CQSQFKPAVF
     DFPSQDVFTV EPQFDTALGQ YFCSITMHRL TDKQRKHLSM KKTALVVSAS LSSSHFSTEQ
     VGAEVPFSPG LFADQAEILL SNHYTSSEIR VFGAPEVLEN LEVKSGSPAV LAFAKEKSFG
     WPSFITYTVG VLDPAAGSQG PLSTTLTFSS PVTNQAIAIP VTVAFVVDRR GPGPYGASLF
     QHFLDSYQVM FFTLFALLAG TAVMIIAYHT VCTPRDLAVP AALTPRASPG HSPHYFAASS
     PTSPNALPPA RKASPPSGLW SPAYASH
//
